<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02889185</url>
  </required_header>
  <id_info>
    <org_study_id>P/2015/249</org_study_id>
    <nct_id>NCT02889185</nct_id>
  </id_info>
  <brief_title>Multimodal Imaging in Central Serous Chorioretinopathy</brief_title>
  <acronym>IMO</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the contribution of the multimodal imaging, combining a routine
      examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive
      optics retinal camera.

      This is a feasibility study with a limited number of patients.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">December 4, 2018</completion_date>
  <primary_completion_date type="Actual">December 4, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Workability of images of RTX1 IMAGIN EYE retinal camera</measure>
    <time_frame>day 1</time_frame>
    <description>Two readings of the images captured with adaptative optics retinal camera and assessment of their workability in routine care.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Central Serous Chorioretinopathy</condition>
  <arm_group>
    <arm_group_label>Adaptative optics retinal camera</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RTX1 IMAGIN EYE retinal camera</intervention_name>
    <description>In addition to the routine examination including OCT, an imaging using RTX1 IMAGIN EYE retinal camera will be performed.</description>
    <arm_group_label>Adaptative optics retinal camera</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent form

          -  Beneficiary/affiliated to French social security/social healthcare

          -  Active ou chronic Central Serous Chorioretinopathy on at least one eye

          -  Absence of other known ophthalmological pathology or of any ophthalmological
             conditions revealed during the examination

        Exclusion Criteria:

          -  Legal incapacity or limited legal capacity

          -  Predictable poor adherence

          -  Subject without health insurance

          -  Pregnant or breatfeeding women

          -  Sujet étant dans la période d'exclusion d'une autre étude ou prévue par le &quot;fichier
             national des volontaires&quot;

          -  Presence of transparent medium opacity damaging images quality

          -  Previous photosensitivity

          -  Recent treatment with PhotoDynamic Therapy (PDT)

          -  Use of drugs inducing photosensitivity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maher Saleh, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Besançon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 31, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2016</study_first_posted>
  <last_update_submitted>September 13, 2019</last_update_submitted>
  <last_update_submitted_qc>September 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Optical Coherence Tomography</keyword>
  <keyword>Retinal camera</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Central Serous Chorioretinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

